Compare ANDE & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDE | ICUI |
|---|---|---|
| Founded | 1947 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2005 | 1995 |
| Metric | ANDE | ICUI |
|---|---|---|
| Price | $71.96 | $124.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $75.00 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 295.2K | 228.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | 12.93 | ★ 100.62 |
| EPS | 0.97 | ★ 1.20 |
| Revenue | ★ $11,008,928,000.00 | $2,231,262,000.00 |
| Revenue This Year | $7.28 | N/A |
| Revenue Next Year | $3.57 | $4.46 |
| P/E Ratio | ★ $73.57 | $104.97 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.84 | $107.02 |
| 52 Week High | $82.11 | $160.29 |
| Indicator | ANDE | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 50.21 |
| Support Level | $69.11 | $121.52 |
| Resistance Level | $74.83 | $125.00 |
| Average True Range (ATR) | 2.65 | 4.82 |
| MACD | -0.92 | 0.69 |
| Stochastic Oscillator | 38.13 | 56.65 |
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.